Skip to content

Summit Therapeutics SMMT Other Non-Current Assets

Other Non-Current Assets at other companies

Incyte logo
IncyteINCY
$24.49M-18.8%
Roivant Sciences logo
Roivant SciencesROIV
$40.92M+24.5%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$94.7M-18.7%
Biogen logo
BiogenBIIB
$777.5M+39.1%
Eli Lilly logo
Eli LillyLLY
$7.23B+19.0%
Exelixis logo
ExelixisEXEL

Other financials

Income statement

See full
Revenue-
Operating income-$65.6M-81.2%
Net income-$189.4M-201%
EPS (diluted)-$0.24-167%

Balance sheet

See full
Cash & equivalents$8.2M+7.2%
Total debt$20.0M+211%
Total equity$545.9M+58.5%
Total assets$647.9M+68.8%

Cash flow

See full
Operating cash flow-$122.3M-99.9%
CapEx$245.0K-41.9%
Free cash flow-$122.5M-99.0%

Valuation

See full
Market cap$10.67B+3.3%
Enterprise value$10.68B+3.4%

Profitability

See full
Operating margin-268,266.8%-272,316pp
Net margin-271,685%-275,966pp
FCF margin-5,931.6%+4,730pp

Returns & leverage

See full
Return on equity-271%-1,725pp
Debt / equity0.0×
Current ratio7.4×-3.2×

Where this comes from

Reported directly by Summit Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Summit Therapeutics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Summit Therapeutics's other non-current assets?
Summit Therapeutics (SMMT) reported other non-current assets of $8.23M in Q1 2026.
How has Summit Therapeutics's other non-current assets changed year-over-year?
Summit Therapeutics's other non-current assets increased by 98.6% year-over-year, from $4.15M to $8.23M.
What does other non-current assets mean?
Miscellaneous long-term assets that are not classified as property, equipment, or goodwill.
How do you interpret other non-current assets?
Significant changes may indicate strategic shifts or changes in long-term tax or investment positions.
How does other non-current assets compare across companies?
Varies widely based on specific accounting policies and business structure.